Literature DB >> 22528248

Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's disease.

C J Yong-Kee1, R Warre, P P Monnier, A M Lozano, J E Nash.   

Abstract

Delineation of how cell death mechanisms associated with Parkinson's disease (PD) interact and whether they converge would help identify targets for neuroprotective therapies. The purpose of this study was to use a cellular model to address these issues. Catecholaminergic SH-SY5Y neuroblastoma cells were exposed to a range of compounds (dopamine, rotenone, 5,8-dihydroxy-1,4-naphtho-107 quinone [naphthazarin], and Z-Ile-Glu(OBut)-Ala-Leu-al [PSI]) that are neurotoxic when applied to these cells for extended periods of times at specific concentrations. At the concentrations used, these compounds cause cellular stress via mechanisms that mimic those associated with causing neurodegeneration in PD, namely oxidative stress (dopamine), mitochondrial dysfunction (rotenone), lysosomal dysfunction (naphthazarin), and proteasomal dysfunction (PSI). The compounds were applied to the SH-SY5Y cells either alone or in pairs. When applied separately, the compounds produced a significant decrease in cell viability confirming that oxidative stress, mitochondrial, proteosomal, or lysosomal dysfunction can individually result in catecholaminergic cell death. When the compounds were applied in pairs, some of the combinations produced synergistic effects. Analysis of these interactions indicates that proteasomal, lysosomal, and mitochondrial dysfunction is exacerbated by dopamine-induced oxidative stress. Furthermore, inhibition of the proteasome or lysosome or increasing oxidative stress has a synergistic effect on cell viability when combined with mitochondrial dysfunction, suggesting that all cell death mechanisms impair mitochondrial function. Finally, we show that there are reciprocal relationships between oxidative stress, proteasomal dysfunction, and mitochondrial dysfunction, whereas lysosome dysfunction appears to mediate cell death via an independent pathway. Given the highly interactive nature of the various cell death mechanisms linked with PD, we predict that effective neuroprotective strategies should target multiple sites in these pathways, for example oxidative stress and mitochondria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528248     DOI: 10.1007/s12640-012-9325-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  25 in total

1.  Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.

Authors:  Ranjita Betarbet; Rosa M Canet-Aviles; Todd B Sherer; Pier G Mastroberardino; Chris McLendon; Jin-Ho Kim; Serena Lund; Hye-Mee Na; Georgia Taylor; Neil F Bence; Ron Kopito; Byoung Boo Seo; Takao Yagi; Akemi Yagi; Gary Klinefelter; Mark R Cookson; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2006-01-24       Impact factor: 5.996

2.  Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

Authors:  Claudia M Testa; Todd B Sherer; J Timothy Greenamyre
Journal:  Brain Res Mol Brain Res       Date:  2005-01-06

3.  Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.

Authors:  Eric K Richfield; Mona J Thiruchelvam; Deborah A Cory-Slechta; Charles Wuertzer; Raul R Gainetdinov; Marc G Caron; Donato A Di Monte; Howard J Federoff
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

4.  Catecholamine metabolism in tissue culture cells of a neuroblastoma.

Authors:  S Imashuku; A Inui; T Nakamura; J Tanaka; S Miyake
Journal:  J Clin Endocrinol Metab       Date:  1973-05       Impact factor: 5.958

5.  Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.

Authors:  C J Yong-Kee; E Sidorova; A Hanif; G Perera; J E Nash
Journal:  Neurotox Res       Date:  2011-07-20       Impact factor: 3.911

6.  Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

Authors:  Günter U Höglinger; Géraldine Carrard; Patrick P Michel; Fadia Medja; Anne Lombès; Merle Ruberg; Bertrand Friguet; Etienne C Hirsch
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

7.  A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.

Authors:  Zongmin Li; Lisette Arnaud; Patricia Rockwell; Maria E Figueiredo-Pereira
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

8.  Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson's disease aetiology.

Authors:  Begoña Caneda-Ferrón; Luigi A De Girolamo; Teresa Costa; Katy E Beck; Robert Layfield; E Ellen Billett
Journal:  J Neurochem       Date:  2007-11-16       Impact factor: 5.372

9.  The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

Authors:  A Lannuzel; P P Michel; G U Höglinger; P Champy; A Jousset; F Medja; A Lombès; F Darios; C Gleye; A Laurens; R Hocquemiller; E C Hirsch; M Ruberg
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease.

Authors:  Todd B Sherer; Jason R Richardson; Claudia M Testa; Byoung Boo Seo; Alexander V Panov; Takao Yagi; Akemi Matsuno-Yagi; Gary W Miller; J Timothy Greenamyre
Journal:  J Neurochem       Date:  2007-01-04       Impact factor: 5.372

View more
  4 in total

1.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

2.  Synergistic stress exacerbation in hippocampal neurons: Evidence favoring the dual-hit hypothesis of neurodegeneration.

Authors:  Scott D Heinemann; Jessica M Posimo; Daniel M Mason; Daniel F Hutchison; Rehana K Leak
Journal:  Hippocampus       Date:  2016-03-29       Impact factor: 3.899

3.  The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.

Authors:  D Jantas; A Roman; J Kuśmierczyk; E Lorenc-Koci; J Konieczny; T Lenda; W Lasoń
Journal:  Neurotox Res       Date:  2013-01-10       Impact factor: 3.911

Review 4.  The Proteasome Inhibition Model of Parkinson's Disease.

Authors:  Eduard Bentea; Lise Verbruggen; Ann Massie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.